Y-MABS THERAPEUTICS INC (YMAB) Forecast, Price Target & Analyst Ratings

NASDAQ:YMAB • US9842411095

Current stock price

8.61 USD
+0.02 (+0.23%)
At close:
8.61 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Y-MABS THERAPEUTICS INC (YMAB).

Forecast Snapshot

Consensus Price Target

Price Target
$8.20
-4.75% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 6, 2025
Period
Q3 / 2025
EPS Estimate
-$0.22
Revenue Estimate
21.437M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
53.75%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.20
Upside
-4.75%
From current price of $8.61 to mean target of $8.20, Based on 16 analyst forecasts
Low
$3.03
Median
$8.77
High
$9.03

Price Target Revisions

1 Month
0.00%
3 Months
-44.03%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for YMAB. The average price target is 8.2 USD. This implies a price decrease of -4.75% is expected in the next year compared to the current price of 8.61.
The average price target has been revised downward by 44.03% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

YMAB Current Analyst RatingYMAB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

YMAB Historical Analyst RatingsYMAB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
53.75%
YMAB was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about YMAB.
In the last month the buy percentage fell by 26 points. So the trust of analysts is decreasing.
YMAB was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-06Canaccord GenuityDowngrade Buy -> Hold
2025-08-06HC Wainwright & Co.Downgrade Buy -> Neutral
2025-08-05Jones TradingDowngrade Buy -> Hold
2025-05-29OppenheimerMaintains Outperform -> Outperform
2025-05-19HC Wainwright & Co.Maintains Buy -> Buy
2025-05-14OppenheimerMaintains Outperform -> Outperform
2025-05-14Truist SecuritiesMaintains Buy -> Buy
2025-03-21HC Wainwright & Co.Maintains Buy -> Buy
2025-03-05Truist SecuritiesMaintains Buy -> Buy
2025-03-05B of A SecuritiesMaintains Neutral -> Neutral
2025-03-05Morgan StanleyMaintains Underweight -> Underweight
2025-01-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-05Brookline CapitalInitiate Buy
2024-11-18OppenheimerInitiate Outperform
2024-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-10WedbushReiterate Outperform -> Outperform
2024-09-09Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-16Cantor FitzgeraldInitiate Overweight
2024-08-13BMO CapitalMaintains Outperform -> Outperform
2024-08-13Canaccord GenuityMaintains Buy -> Buy
2024-08-13Morgan StanleyMaintains Underweight -> Underweight
2024-08-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-11Jones TradingInitiate Buy
2024-06-28Truist SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 6, 2025
Period
Q3 / 2025
EPS Estimate
-$0.22
Revenue Estimate
21.437M
Revenue Q2Q
16.12%
EPS Q2Q
-37.70%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
0.53%
Revenue (3 Months)
0.02%
EPS (1 Month)
3.14%
EPS (3 Months)
22.86%

Next Earnings Summary

YMAB is expected to report earnings on 11/6/2025. The consensus EPS estimate for the next earnings is -0.22 USD and the consensus revenue estimate is 21.44M USD.
The next earnings revenue estimate has been revised upward by 0.02% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
YMAB revenue by date.YMAB revenue by date.
65.27M
87.02%		84.819M
29.95%		87.685M
3.38%		84.852M
-3.23%		96.267M
13.45%		109.8M
14.06%		134.8M
22.77%		205.43M
52.40%		302.19M
47.10%		264.44M
-12.49%		392.63M
48.48%
EBITDA
YoY % growth
YMAB ebitda by date.YMAB ebitda by date.
-93.97M
18.04%		-20.455M
78.23%		-29.143M
-42.47%		-48.202M
-65.40%		-45.944M
4.68%		-46.821M
-1.91%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
YMAB ebit by date.YMAB ebit by date.
-94.81M
17.86%		-21.19M
77.65%		-29.678M
-40.06%		-41.986M
-41.47%		-55.016M
-31.03%		-65.376M
-18.83%		-57.618M
11.87%		-16.276M
71.75%		50.463M
410.05%		12.324M
-75.58%		87.674M
611.41%
Operating Margin
YMAB operating margin by date.YMAB operating margin by date.
-145.26%-24.98%-33.85%-49.48%-57.15%-59.54%-42.74%-7.92%16.70%4.66%22.33%
EPS
YoY % growth
YMAB eps by date.YMAB eps by date.
-2.18
19.85%		-0.49
77.52%		-0.67
-36.73%		-0.84
-24.97%		-0.95
-14.02%		-1.09
-14.47%		-0.79
28.13%		-0.27
65.19%		0.50
282.84%		0.45
-9.53%		1.23
171.44%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.22
-37.70%		-0.29
-95.16%		-0.26
-114.20%		-0.25
-258.46%		-0.24
-7.41%		-0.23
21.95%
Revenue
Q2Q % growth		21.437M
16.12%		23.265M
-12.19%		21.464M
2.68%		22.421M
14.83%		23.338M
8.87%		24.418M
4.96%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-10.174M
-18.74%		-11.758M
-166.45%		-14.84M
-126.80%		-14.481M
-158.40%		-14.219M
-39.77%		-13.471M
-14.57%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

YMAB Yearly Revenue VS EstimatesYMAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
YMAB Yearly EPS VS EstimatesYMAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-17.71%
EPS Next 5 Year
9.75%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.75%
Revenue Next 5 Year
17.88%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-14.78%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Y-MABS THERAPEUTICS INC / YMAB Forecast FAQ

What is the price target for YMAB stock?

16 analysts have analysed YMAB and the average price target is 8.2 USD. This implies a price decrease of -4.75% is expected in the next year compared to the current price of 8.61.

When does Y-MABS THERAPEUTICS INC (YMAB) report earnings?

Y-MABS THERAPEUTICS INC (YMAB) will report earnings on 2025-11-06, after the market close.

Can you provide the consensus estimates for Y-MABS THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of Y-MABS THERAPEUTICS INC (YMAB) is -0.22 USD and the consensus revenue estimate is 21.44M USD.

Can you provide the expected long term growth rate for Y-MABS THERAPEUTICS INC stock?

The expected long term growth rate for Y-MABS THERAPEUTICS INC (YMAB) is 6.75%.